ArticleUrologic oncology
No evidence for association of the MDM2-309 T/G promoter polymorphism with prostate cancer outcomes.
Jerry J Jaboin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
pooled itcites it
ArticleUrologic oncology
Jerry J Jaboin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.